Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DuPont Capital Management is an institutional asset management firm and a wholly-owned subsidiary of DuPont. Originally established to manage the pension assets of its parent company, the firm has since expanded to offer a variety of investment strategies to external institutional clients, including pension funds, endowments, and foundations. Their investment expertise covers global equities, fixed income, and alternative asset classes such as private equity and real estate. Headquartered in Wilmington, Delaware, the firm operates as a registered investment advisor with the U.S. Securities and Exchange Commission. While it is part of a major science and technology conglomerate, its primary business is fiduciary asset management rather than biotechnology research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DuPont Capital Management.